N<sup>4</sup>-Acetylcytidine, 97.5%|237926|3768-18-1

N⁴-Acetylcytidine, 97.5%

Name: N4-Acetylcytidine, 97.5% | 3768-18-1
Brand: J&K Chemical
SKU: JK237926_1_G
Price: 80.0 USD
Availability: OutOfStock

Cat. No JK237926_1_G

Vendor: J&K Chemical

Product Information

Product Name

N⁴-Acetylcytidine, 97.5%

Brand Name

J&K

Product Number

237926

CAS

3768-18-1

Certificate of Analysis (COA)

COA not found

General Information

PubChem CID

107461

IUPAC Name

N-1-(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl-2-oxopyrimidin-4-ylacetamide

InChI Key

NIDVTARKFBZMOT-PEBGCTIMSA-N

SMILES

CC(=O)NC1=NC(=O)N(C=C1)C@H2C@@H(C@@H(C@H(O2)CO)O)O

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

Integrative single-cell and machine-learning analysis identifies ac4C-related S100A13 as a causal risk gene in cholangiocarcinoma

Publication Name: BMC Cancer

Publication Date: 2026-01-23

DOI: 10.1186/s12885-026-15602-5

NAT10 promotes the activation of hepatic stellate cells by modulating the TGF-β1-ac4C-COL1A1 axis

Publication Name: Hepatology International

Publication Date: 2026-01-20

DOI: 10.1007/s12072-025-10998-x

NAT10 promotes the glycolysis of retinoblastoma through ac4C modification of PFKFB3 mRNA

Publication Name: BMC Cancer

Publication Date: 2026-01-16

DOI: 10.1186/s12885-026-15546-w

Regulation of apoptosis, ferroptosis, and pyroptosis mediated by acetylation

Publication Name: Cell Death Discovery

Publication Date: 2026-01-09

DOI: 10.1038/s41420-025-02859-1

Integrins as key regulators in tumor perineural invasion: mechanisms and clinical implications

Publication Name: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Publication Date: 2026-01-08

DOI: 10.1007/s12094-025-04196-2

N⁴-Acetylcytidine, 97.5%

Product Information

General Information

Safety Information

References Data Source From Pubchem

Integrative single-cell and machine-learning analysis identifies ac4C-related S100A13 as a causal risk gene in cholangiocarcinoma

NAT10 promotes the activation of hepatic stellate cells by modulating the TGF-β1-ac4C-COL1A1 axis

NAT10 promotes the glycolysis of retinoblastoma through ac4C modification of PFKFB3 mRNA

Regulation of apoptosis, ferroptosis, and pyroptosis mediated by acetylation

Integrins as key regulators in tumor perineural invasion: mechanisms and clinical implications